These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 34880908)
1. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z Front Genet; 2021; 12():779554. PubMed ID: 34880908 [No Abstract] [Full Text] [Related]
2. Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma. Duan BT; Zhao XK; Cui YY; Liu DZ; Wang L; Zhou L; Zhang XY World J Gastrointest Surg; 2024 Mar; 16(3):842-859. PubMed ID: 38577085 [TBL] [Abstract][Full Text] [Related]
3. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma. Zhu J; Huang Q; Liu S; Peng X; Xue J; Feng T; Huang W; Chen Z; Lai K; Ji Y; Wang M; Yuan R Front Immunol; 2022; 13():856186. PubMed ID: 35479067 [TBL] [Abstract][Full Text] [Related]
4. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma. Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469 [TBL] [Abstract][Full Text] [Related]
5. A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer. Guo C; Zhou J; Ma B; Wang R; Ge Y; Wang Z; Ji B; Wang W; Zhang J; Wang Z Front Surg; 2021; 8():724792. PubMed ID: 34504866 [No Abstract] [Full Text] [Related]
6. A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma Prognosis. Lu J; Cao W; He Z; Wang H; Hao J; Xu J J Oncol; 2022; 2022():3090523. PubMed ID: 36072979 [TBL] [Abstract][Full Text] [Related]
7. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma. Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
9. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233 [TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma. Chen Y; Zhao Y; Lu R; Zhao H; Guo Y Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708 [No Abstract] [Full Text] [Related]
11. Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer. Tang L; Li W; Xu H; Zheng X; Qiu S; He W; Wei Q; Ai J; Yang L; Liu J Front Oncol; 2022; 12():876531. PubMed ID: 35860569 [TBL] [Abstract][Full Text] [Related]
12. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment. Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N Front Genet; 2021; 12():706661. PubMed ID: 34712264 [No Abstract] [Full Text] [Related]
13. Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma. Yang L; Guo G; Yu X; Wen Y; Lin Y; Zhang R; Zhao D; Huang Z; Wang G; Yan Y; Zhang X; Chen D; Xing W; Wang W; Zeng W; Zhang L Front Oncol; 2022; 12():780631. PubMed ID: 35372012 [TBL] [Abstract][Full Text] [Related]
14. Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer. Zhu X; Yu R; Peng Y; Miao Y; Jiang K; Li Q Front Genet; 2022; 13():990661. PubMed ID: 36118868 [No Abstract] [Full Text] [Related]
15. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma. Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708 [TBL] [Abstract][Full Text] [Related]
16. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma. Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420 [TBL] [Abstract][Full Text] [Related]
17. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma. Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z Front Genet; 2022; 13():874673. PubMed ID: 35547247 [No Abstract] [Full Text] [Related]
20. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]